NASDAQ NMS - GLOBAL MARKET · ABOS
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Acumen Pharmaceuticals Inc

Acumen Pharmaceuticals Inc

Biotechnology
$3.08
Card
Relationship Map

Veridion Score

BETALOW CONF · 5/6 factorsMethodology
Sentiment absence reason unknown
ABOS
Acumen Pharmaceuticals Inc
Mon Aug 24 · last completed session · Pre-market · regular session opens 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

59/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 5/6 factors with data · Mon Aug 24 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is ABOS moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading ABOS catalysts
About Acumen Pharmaceuticals Inc
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed since
2021
Employees
61
Country
US

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$3.08
Last session
Day high
$3.08
Last session
Day low
$3.08
Last session
Previous close
$3.08
52W high
$3.37
-8.75% from high
52W low
$1.23
86% of range
Market cap
$222.4M
EPS
$-1.9000
Beta
1.51
Shares out
72.3M
Avg volume
387.5K
VWAP
$3.08
Last session
Price history computed in-house
1W
+12.23%
1M
+44.37%
3M
+21.06%
1Y
+103.64%
YTD
+45.73%
SMA 50 $2.46 · above
SMA 200 $2.39 · above
52W position 86%

ABOS overview

Veridion Score
59
Registered · 2026-08-24
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around ABOS.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading ABOS Form 4 filings
Public disclosures

Congress activity in ABOS

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for ABOS in the cached public ledger.

Federal contracts

ABOS contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ABOS in this window.
Lobbying spend

ABOS lobbying filings, year to date.

Registered lobbying filings matched to Acumen Pharmaceuticals Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ABOS in this window.
Loading news for ABOS
Analyst ratings
Sovereign unlock shows live analyst consensus for ABOS.
Options
Sovereign unlock shows live options positioning for ABOS.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.